drugset / Trial / NCT04131517

A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants

NCT04131517

Phase 1 Terminated 14 enrolled UCB Biopharma SRL
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of the study is to investigate the effect of steady-state padsevonil on the pharmacokinetic of a single dose oral contraceptive.

Timeline

Start
2019-10-23
Primary completion
2020-05-22
Completion
2020-05-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Microgynon 30® Unknown 30 ug Oral
Subject Microgynon 30® Unknown 150 ug Oral
Subject Padsevonil Small molecule 200 mg Oral
Subject Padsevonil Small molecule 400 mg Oral

Indications

No indication recorded.